obesity drug news today glp-1 today Study predicts 16 new drugs may come to market New GLP-1 drug helps patients

While lifestyle interventions are the cornerstone of obesity prevention and management, they often fail to result in sustained and meaningful weight loss (WL)

Zulaikhah ST, Wahyuwibowo J, Pratama AA

This result is consistent with the findings of Haghighatdoost et al

These include improving vascular function, reducing systemic inflammation, enhancing coronary microvascular function, and mitigating comorbid conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD)

The SL comorbidity was insignificant among patients with a diagnosis of BCC, but BCC was found in all patients with melanoma with NMSC comorbidity